Stay updated with breaking news from Fda Approves. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration announced the supplemental approval of Rexulti (brexpiprazole) oral tablets to treat agitation associated with dementia due to Alzheimer's disease.
The U.S. Food and Drug Administration approved Gamida Cell Ltd.'s Omisirge (omidubicel-onlv) cell therapy for patients with blood cancers to reduce risk of infection following stem cell transplantation.
In a move that will make the drug more accessible, the US Food and Drug Administration (FDA) has approved the first over-the-counter (OTC) version of Narcan, a naloxone hydrochloride nasal spray, for the treatment of opioid overdose. Read more.